封面
市场调查报告书
商品编码
1451733

2024-2032 年按产品、疾病、给药途径、配销通路和地区分類的猪隻保健品市场报告

Swine Healthcare Market Report by Product, Disease, Route of Administration, Distribution Channel, and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2023年,全球猪隻保健市场规模达到30亿美元。展望未来, IMARC Group预计到2032年市场规模将达到53亿美元,2024-2032年复合年增长率(CAGR)为6.48%。对生猪产品的日益依赖、商业生猪养殖和出口活动的大幅增加以及对猪肉传播疾病的认识不断增强,是推动市场发展的一些关键因素。

猪保健是指一系列旨在减轻猪疾病期间不适的产品、治疗程序和诊断试剂盒。它的重点是治疗不孕症和先天性异常等与猪相关的常见疾病,以及开发预防此类疾病的疗法。协调的全球疾病监测、最大限度地减少未来威胁影响的有针对性的研究投资以及资料分析是猪隻医疗保健管理的一部分。除此之外,它还包括预防病毒和细菌,同时透过适当的定时疫苗接种和负责任的抗生素使用来增强牛群疾病免疫力。除了为生猪提供健康服务外,生猪医疗保健系统还透过猪舍设计、猪隻运输、疫苗接种方案、猪群健康监测、疾病监测和适合具体情况的诊断测试,促进最大限度地降低疾病风险。

群众对生猪产品的依赖程度不断增加是推动市场成长的关键因素之一。这可以归因于全球商业养猪和出口活动的大幅成长。同时,包括猪流感、沙门氏菌、猪肺炎支原体和猪瘟(CSF)在内的多种疾病的盛行率不断上升,正在推动市场的发展。此外,人们对猪肉传播疾病的认识不断增强,导致猪隻保健品的使用量增加。此外,政府机构为维护猪隻的健康所采取的有利措施也推动了市场的成长。不断增长的猪肉消费群体推动了对健康生猪牲畜的需求,这进一步为市场提供了动力。除此之外,广泛的研发(R&D)活动,尤其是开发预防猪流感和猪瘟的疫苗以及减少猪病对人类的影响,也为市场做出了贡献。此外,兽医医院越来越多地采用诊断影像,导致对配件和诊断设备的需求不断增加,这也为市场做出了贡献。创造积极市场前景的其他一些因素包括疫苗、抗生素和手术治疗的采用率不断提高,以提高牲畜产量,食源性疾病发病率显着上升,全球化的迅速发展,对有机猪肉的需求不断增加,以及相当大的食品和饮料 (F&B) 行业的成长。

本报告回答的关键问题

  • 全球猪保健市场有多大?
  • 2024-2032年全球猪隻保健市场的预期成长率是多少?
  • 推动全球猪保健市场的关键因素是什么?
  • COVID-19 对全球猪隻保健市场有何影响?
  • 根据该产品,全球猪保健品市场的细分如何?
  • 基于该疾病,全球猪保健市场的细分如何?
  • 全球猪隻保健品市场的重点区域有哪些?
  • 全球猪保健市场的主要参与者/公司有哪些?

目录

第一章:前言

第 2 章:范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章:执行摘要

第 4 章:简介

  • 概述
  • 主要行业趋势

第 5 章:全球猪保健市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章:市场区隔:依产品

  • 诊断测试
    • 市场走向
    • 关键环节
      • 酵素连结免疫吸附测定法 (ELISA)
      • 快速免疫迁移(RIM)
      • 琼脂凝胶免疫扩散 (AGID)
      • 聚合酶炼式反应 (PCR)
      • 诊断影像
      • 其他的
    • 市场预测
  • 疗法
    • 市场走向
    • 关键环节
      • 疫苗
      • 杀寄生虫剂
      • 抗感染药
      • 饲料添加剂
      • 其他的
    • 市场预测

第 7 章:市场区隔:依疾病分类

  • 渗出性皮肤炎
    • 市场走向
    • 市场预测
  • 球虫病
    • 市场走向
    • 市场预测
  • 呼吸疾病
    • 市场走向
    • 市场预测
  • 猪痢疾
    • 市场走向
    • 市场预测
  • 猪细小病毒
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章:市场区隔:依管理途径

  • 可注射
    • 市场走向
    • 市场预测
  • 口服
    • 市场走向
    • 市场预测

第 9 章:市场区隔:按配销通路

  • 兽医院
    • 市场走向
    • 市场预测
  • 零售药房
    • 市场走向
    • 市场预测
  • 网路药房
    • 市场走向
    • 市场预测

第 10 章:市场区隔:按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分:按国家/地区
    • 市场预测

第 11 章:驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 12 章:价值链分析

第 13 章:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章:价格分析

第15章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Boehringer Ingelheim International GmbH
    • Ceva Animal Health Inc.
    • Elanco
    • IDEXX Laboratories Inc.
    • Innovative Diagnostic
    • Merck & Co. Inc.
    • Phibro Animal Health Corporation
    • Vetoquinol
    • Virbac Corporation
    • Zoetis Inc.
Product Code: SR112024A6654

The global swine healthcare market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.48% during 2024-2032. The increasing dependency on swine products, a considerable rise in commercial swine farming and export activities, and the growing awareness regarding pork-transmitted diseases represent some of the key factors driving the market.

Swine healthcare refers to a broad category of products, treatment procedures, and diagnostic kits that aim to alleviate discomfort during swine diseases. It focuses on treatments for common pig-related disorders like infertility and congenital anomalies as well as the development of therapeutics to prevent such diseases. Coordinated global disease monitoring, targeted research investments that minimize future threat effects, and data analysis are part of swine healthcare management. Along with this, it involves the prevention of viruses and bacteria while enhancing herd disease immunity with appropriately timed vaccinations and responsible antibiotic use. In addition to providing health services to pigs, the swine healthcare system promotes minimizing disease risks through barn design, pig movement, vaccination protocols, herd health monitoring, disease surveillance, and diagnostic tests that are appropriate for the situation.

The increasing dependency on swine products among the masses is one of the key factors driving the growth of the market. This can be attributed to a considerable rise in commercial swine farming and export activities across the globe. In line with this, the rising prevalence of numerous diseases, including swine flu, salmonella, mycoplasma hyopneumoniae, and classical swine fever (CSF), is fueling the market. Moreover, the augmenting awareness regarding pork-transmitted diseases is resulting in a higher uptake of swine healthcare products. Also, favorable initiatives taken by government bodies toward swine health maintenance are fueling the market growth. The continuously growing pork-eating population is propelling the demand for healthy swine livestock, which is further providing an impetus to the market. Besides this, extensive research and development (R&D) activities with an enhanced focus on the development of vaccines to prevent swine flu and swine fever and reduce the effects of swine diseases on humans are contributing to the market. Additionally, the augmenting incorporation of diagnostic imaging in veterinary hospitals leading to an escalating demand for accessories and diagnostic equipment is contributing to the market. Some of the other factors creating a positive market outlook include the growing adoption rates of vaccines, antibiotics, and surgical treatments for increasing livestock production, a significant rise in the rates of foodborne diseases, rapid globalization, the accelerating demand for organic pork, and considerable growth in the food and beverage (F&B) industry.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global swine healthcare market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, disease, route of administration and distribution channel.

Product Insights:

Diagnostic Tests

Enzyme Linked Immuno-Sorbent Assay (ELISA)

Rapid Immuno Migration (RIM)

Agar Gel Immuno-Diffusion (AGID)

Polymerase Chain Reaction (PCR)

Diagnostic Imaging

Others

Therapeutics

Vaccines

Parasiticides

Anti-infectives

Feed Additives

Others

The report has also provided a detailed breakup and analysis of the swine healthcare market based on the product. This includes diagnostic tests (Enzyme Linked Immuno-Sorbent Assay (ELISA), Rapid Immuno Migration (RIM), Agar Gel Immuno-Diffusion (AGID), Polymerase Chain Reaction (PCR), Diagnostic Imaging, and others) and therapeutics (vaccines, parasiticides, anti-infectives, feed additives, and others). According to the report, therapeutics represented the largest segment.

Disease Insights:

Exudative Dermatitis

Coccidiosis

Respiratory Diseases

Swine Dysentery

Porcine Parvovirus

Others

A detailed breakup and analysis of the swine healthcare market based on the disease has also been provided in the report. This includes exudative dermatitis, coccidiosis, respiratory diseases, swine dysentery, porcine parvovirus, and others. According to the report, respiratory diseases accounted for the largest market share.

Route of Administration Insights:

Injectable

Oral

A detailed breakup and analysis of the swine healthcare market based on the route of administration has also been provided in the report. This includes injectable and oral.

Distribution Channel Insights:

Veterinary Hospitals

Retail Pharmacy

Online Pharmacy

A detailed breakup and analysis of the swine healthcare market based on the distribution channel has also been provided in the report. This includes veterinary hospitals, retail pharmacy and online pharmacy.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for swine healthcare. Some of the factors driving the North America swine healthcare market included the growing consumption of pork, improving animal healthcare infrastructure, the growing consciousness regarding pork-transmitted diseases, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global swine healthcare market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva Animal Health Inc., Elanco, IDEXX Laboratories Inc., Innovative Diagnostic, Merck & Co. Inc., Phibro Animal Health Corporation, Vetoquinol, Virbac Corporation, Zoetis Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global swine healthcare market?
  • 2. What is the expected growth rate of the global swine healthcare market during 2024-2032?
  • 3. What are the key factors driving the global swine healthcare market?
  • 4. What has been the impact of COVID-19 on the global swine healthcare market?
  • 5. What is the breakup of the global swine healthcare market based on the product?
  • 6. What is the breakup of the global swine healthcare market based on the disease?
  • 7. What are the key regions in the global swine healthcare market?
  • 8. Who are the key players/companies in the global swine healthcare market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Swine Healthcare Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Diagnostic Tests
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Enzyme Linked Immuno-Sorbent Assay (ELISA)
      • 6.1.2.2 Rapid Immuno Migration (RIM)
      • 6.1.2.3 Agar Gel Immuno-Diffusion (AGID)
      • 6.1.2.4 Polymerase Chain Reaction (PCR)
      • 6.1.2.5 Diagnostic Imaging
      • 6.1.2.6 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Vaccines
      • 6.2.2.2 Parasiticides
      • 6.2.2.3 Anti-infectives
      • 6.2.2.4 Feed Additives
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Disease

  • 7.1 Exudative Dermatitis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Coccidiosis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Respiratory Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Swine Dysentery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Porcine Parvovirus
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Injectable
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Veterinary Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacy
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Boehringer Ingelheim International GmbH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Ceva Animal Health Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Elanco
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 IDEXX Laboratories Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Innovative Diagnostic
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Merck & Co. Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Phibro Animal Health Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Vetoquinol
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Virbac Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Zoetis Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

List of Figures

  • Figure 1: Global: Swine Healthcare Market: Major Drivers and Challenges
  • Figure 2: Global: Swine Healthcare Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Swine Healthcare Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Swine Healthcare Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Swine Healthcare Market: Breakup by Disease (in %), 2023
  • Figure 6: Global: Swine Healthcare Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Swine Healthcare Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Swine Healthcare Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Swine Healthcare (Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Swine Healthcare (Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Swine Healthcare (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Swine Healthcare (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Swine Healthcare (Exudative Dermatitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Swine Healthcare (Exudative Dermatitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Swine Healthcare (Coccidiosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Swine Healthcare (Coccidiosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Swine Healthcare (Respiratory Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Swine Healthcare (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Swine Healthcare (Swine Dysentery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Swine Healthcare (Swine Dysentery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Swine Healthcare (Porcine Parvovirus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Swine Healthcare (Porcine Parvovirus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Swine Healthcare (Other Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Swine Healthcare (Other Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Swine Healthcare (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Swine Healthcare (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Swine Healthcare (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Swine Healthcare (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Swine Healthcare (Veterinary Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Swine Healthcare (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Swine Healthcare (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Swine Healthcare (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Swine Healthcare (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Swine Healthcare (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: North America: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: North America: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: United States: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: United States: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Canada: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Canada: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Asia-Pacific: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Asia-Pacific: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: China: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: China: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Japan: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Japan: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: India: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: India: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: South Korea: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: South Korea: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Australia: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Australia: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Indonesia: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Indonesia: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Europe: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Europe: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Germany: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Germany: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: France: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: France: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: United Kingdom: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: United Kingdom: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Italy: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Italy: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Spain: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Spain: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Russia: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Russia: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Latin America: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Latin America: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Brazil: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Brazil: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Mexico: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Mexico: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Middle East and Africa: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Middle East and Africa: Swine Healthcare Market: Breakup by Country (in %), 2023
  • Figure 83: Middle East and Africa: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Global: Swine Healthcare Industry: Drivers, Restraints, and Opportunities
  • Figure 85: Global: Swine Healthcare Industry: Value Chain Analysis
  • Figure 86: Global: Swine Healthcare Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Swine Healthcare Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Swine Healthcare Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Swine Healthcare Market Forecast: Breakup by Disease (in Million US$), 2024-2032
  • Table 4: Global: Swine Healthcare Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Swine Healthcare Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Swine Healthcare Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Swine Healthcare Market: Competitive Structure
  • Table 8: Global: Swine Healthcare Market: Key Players